Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;32(4):506-515.
doi: 10.1097/MOP.0000000000000921.

Pediatric nail disorders: a review

Affiliations
Review

Pediatric nail disorders: a review

Robert J Smith et al. Curr Opin Pediatr. 2020 Aug.

Abstract

Purpose of review: Nail disorders represent an uncommon subset of complaints seen in pediatric dermatology. There is a wide array of disorders that can affect the nail unit in children, including infectious, inflammatory, neoplastic, congenital, and traumatic processes. In order to enhance familiarity with pediatric nail conditions, we review the background and treatment of the more common entities seen in pediatric onychology, including onychomycosis, onychomadesis, nail psoriasis, trachyonychia, longitudinal melanonychia, onychophagia, and onychocryptosis.

Recent findings: Nail involvement in pediatric patients with psoriasis may indicate increased risk for both overall disease severity and the development psoriatic arthritis. In the evaluation of longitudinal melanonychia, the clinical findings that raise concern for subungual melanoma in adults are often found in benign nail unit nevi in children. In the systemic treatment of pediatric onychomycosis, new data raises the possibility that laboratory monitoring may be approached differently. In the approach to onychophagia, emerging pharmacotherapies include N-acetylcysteine.

Summary: Most nail disorders in pediatric patients have an overall favorable prognosis. However, nail abnormalities can lead to patient and parental anxiety, decreased quality of life, pain, and functional impairment. Clinicians should be aware of these more common diverse entities in order to identify them and apply state of the art management for these issues. Additionally, the reader will learn factors related to these nail disorders, which may require systemic work-up and/or specialist referral.

PubMed Disclaimer

References

    1. Wulkan AJ, Tosti A. Pediatric nail conditions. Clin Dermatol 2013; 31:564–572.
    1. Iglesias A, Tamayo L, Sosa-de-Martínez C, et al. Prevalence and nature of nail alterations in pediatric patients. Pediatr Dermatol 2001; 18:107–109. Accessed 25 June 2020.
    1. Tasia M, Lecerf P, Richert B, André J. Paediatric nail consultation in an academic centre in Belgium: a 10-year retrospective study. J Eur Acad Dermatol Venereol 2019; 33:1800–1805.
    1. Gupta AK, Mays RR, Versteeg SG, et al. Onychomycosis in children: safety and efficacy of antifungal agents. Pediatr Dermatol 2018; 35:552–559.
    1. Young LS, Arbuckle HA, Morelli JG. Onychomycosis in the Denver pediatrics population, a retrospective study. Pediatr Dermatol 2014; 31:106–108.